M, S. A., M, B. A., Aisha, S., Judith, A., M, M. R., & M, A. A. (2012). HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (<it>cis</it>-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas. BMC.

M, Sosin Angela, Burger Angelika M, Siddiqi Aisha, Abrams Judith, Mohammad Ramzi M, and Al-Katib Ayad M. HDM2 Antagonist MI-219 (spiro-oxindole), but Not Nutlin-3 (<it>cis</it>-imidazoline), Regulates P53 Through Enhanced HDM2 Autoubiquitination and Degradation in Human Malignant B-cell Lymphomas. BMC, 2012.

M, Sosin Angela, et al. HDM2 Antagonist MI-219 (spiro-oxindole), but Not Nutlin-3 (<it>cis</it>-imidazoline), Regulates P53 Through Enhanced HDM2 Autoubiquitination and Degradation in Human Malignant B-cell Lymphomas. BMC, 2012.